Jiangsu Hengrui Medicine
600276.SS
#488
Rank
$42.07 B
Marketcap
$6.60
Share price
-1.55%
Change (1 day)
2.27%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): $0.09091

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.09091. In 2022 the company made an earnings per share (EPS) of $0.09065 a decrease over its 2021 EPS that were of $0.11.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.090910.29%
2022$0.09065-17.1%
2021$0.11-24.44%
2020$0.1420.3%
2019$0.1225.58%
2018$0.0957927.55%
2017$0.0751021.64%
2016$0.0617413.57%
2015$0.0543639.86%
2014$0.0388721.33%
2013$0.0320317.7%
2012$0.0272225.56%
2011$0.0216826.22%
2010$0.0171710.3%
2009$0.0155757.92%
2008$0.00985911.06%
2007$0.00887785.81%
2006$0.00477887.94%
2005$0.00254233.97%
2004$0.00189729.78%
2003$0.00146219.78%
2002$0.001221